Cumberland Pharmaceuticals Inc.

CPIX | NASDAQ

Price Alert Chart Builder DCF Calculator

$8.08

+$0.49 (+6.46%)

Sep 22, 2026, 2:14 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+6.46%

(1D)

Rating

Updated: Aug 29, 2026

31.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $120.99M

1D Range

7.50 8.09

52W Range

1.85 9.28

Valuation (TTM)

PE -10.69

PB 6.52

EV/EBITDA -20.29

Valuation (NTM)

Forward PE N/A

Forward PEG 0.08

Price Target N/A

Cash Flow

FCF Yield 0.9%

SBC Adj. FCF Yield 0.4%

SBC Impact -53.3%

Margins

Gross Margin 83.4%

Operating Margin -30.8%

FCF Margin 3.3%

Growth (CAGR)

Revenue 3Y | 5Y -8.4% | -4.4%

Dil EPS 3Y | 5Y 1.8% | -10.7%

FCF 3Y | 5Y -49.5% | -26.4%

Returns

ROA -16.9%

ROE -47.1%

ROIC -34.1%

Financial Health

Net Cash

$3.86M

Current Ratio 0.96

Interest Coverage -31.13

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Cumberland Pharmaceuticals Inc. functions as a specialized pharmaceutical enterprise, primarily involved in the procurement, advancement, and commercialization of prescription medications. Its strateg...

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

Employees 88

IPO Date Aug 10, 2009

Website www.cumberlandpharma.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 3, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞